Desmoplastic malignant melanoma. 1995

H G Skelton, and K J Smith, and W B Laskin, and W F McCarthy, and J M Gagnier, and J H Graham, and G P Lupton
Department of Dermatopathology, Armed Forces Institute of Pathology, Washington, DC 20306-6000, USA.

BACKGROUND Desmoplastic malignant melanoma (DMM) is an uncommon variant of malignant melanoma and often is difficult to diagnose. Because of the relative rarity of this tumor, it has not been well studied and controversy remains concerning its biologic potential. OBJECTIVE We compared survival rates of DMM with those of other malignant melanomas and determined what clinical and/or histologic features, if any, correlated with survival. METHODS The files of the Armed Forces Institute of Pathology were searched for cases of DMM or related tumors with adequate material for further histologic and immunohistochemical evaluation. Follow-up on each patient was requested from the pathologist, clinician, and/or the patient. The follow-up was correlated with the histologic findings in each case. The relationship of histologic features to disease-free survival was evaluated. RESULTS Adequate material for evaluation was available in 128 cases. The overall histologic features were similar to those previously reported. Immunohistochemical studies showed that all lesions were negative for HMB-45, a marker for premelanosomes. Factors that correlated with survival included tumor location, sex, tumor depth, and the presence of stromal mucin. The 5-year disease-free survival rate was 68% for all cases and 61% for lesions more than 4 mm deep. CONCLUSIONS With a 5-year disease-free survival rate of 61%, DMM has a significantly better prognosis than other melanomas that have a 5-year disease-free survival rates of 40% to 41%. This may be related to neural differentiation of these tumors.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008297 Male Males
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

H G Skelton, and K J Smith, and W B Laskin, and W F McCarthy, and J M Gagnier, and J H Graham, and G P Lupton
June 1975, Archives of dermatology,
H G Skelton, and K J Smith, and W B Laskin, and W F McCarthy, and J M Gagnier, and J H Graham, and G P Lupton
April 1996, Journal of the American Academy of Dermatology,
H G Skelton, and K J Smith, and W B Laskin, and W F McCarthy, and J M Gagnier, and J H Graham, and G P Lupton
January 1999, Arkhiv patologii,
H G Skelton, and K J Smith, and W B Laskin, and W F McCarthy, and J M Gagnier, and J H Graham, and G P Lupton
July 1982, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete,
H G Skelton, and K J Smith, and W B Laskin, and W F McCarthy, and J M Gagnier, and J H Graham, and G P Lupton
February 1979, Zeitschrift fur Hautkrankheiten,
H G Skelton, and K J Smith, and W B Laskin, and W F McCarthy, and J M Gagnier, and J H Graham, and G P Lupton
January 1991, Journal of the Royal Society of Medicine,
H G Skelton, and K J Smith, and W B Laskin, and W F McCarthy, and J M Gagnier, and J H Graham, and G P Lupton
January 1994, Pathology (Philadelphia, Pa.),
H G Skelton, and K J Smith, and W B Laskin, and W F McCarthy, and J M Gagnier, and J H Graham, and G P Lupton
February 2016, Journal of the European Academy of Dermatology and Venereology : JEADV,
H G Skelton, and K J Smith, and W B Laskin, and W F McCarthy, and J M Gagnier, and J H Graham, and G P Lupton
February 1995, Pathologica,
H G Skelton, and K J Smith, and W B Laskin, and W F McCarthy, and J M Gagnier, and J H Graham, and G P Lupton
March 1995, Plastic and reconstructive surgery,
Copied contents to your clipboard!